The Latin America, Middle East and Africa E-coli Testing Market is projected to witness market growth of 8.9% CAGR during the forecast period (2024-2031).
The Brazil market dominated the LAMEA E-coli Testing Market by country in 2023, and is projected to continue to be a dominant market till 2031; thereby, achieving a market value of $62 Million by 2031. The Argentina market is showcasing a CAGR of 10.1% during 2024-2031. Additionally, the UAE market would register a CAGR of 7.8% during 2024-2031.
E-coli is a common cause of urinary tract infections (UTIs) and other clinical conditions. Testing for E-coli in clinical samples, such as urine or blood, helps diagnose infections and determine the appropriate treatment. In clinical settings, E-coli testing often includes evaluating antibiotic resistance patterns.
Moreover, this information is critical for selecting effective antibiotics and managing antibiotic-resistant strains of E-coli. E-coli testing is used in surveillance programs to track the incidence and patterns of infections. This data helps public health authorities monitor trends and respond to outbreaks effectively.
The UAE government has heavily invested in expanding healthcare infrastructure, including the construction of new hospitals and clinics. This expansion increases the demand for advanced diagnostic testing, including E-coli testing, to ensure the safety and health of patients. According to the International Trade Administration (ITA), in the UAE's 2022 federal budget, a total of USD 15.8 billion (AED 58.931 billion) was approved for public spending, of which 8.4% is dedicated to healthcare.
Based on Test, the market is segmented into Environmental Test, and Clinical Test. Based on End User, the market is segmented into Diagnostic Laboratories, Hospitals, and Physicians Offices. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The Brazil market dominated the LAMEA E-coli Testing Market by country in 2023, and is projected to continue to be a dominant market till 2031; thereby, achieving a market value of $62 Million by 2031. The Argentina market is showcasing a CAGR of 10.1% during 2024-2031. Additionally, the UAE market would register a CAGR of 7.8% during 2024-2031.
E-coli is a common cause of urinary tract infections (UTIs) and other clinical conditions. Testing for E-coli in clinical samples, such as urine or blood, helps diagnose infections and determine the appropriate treatment. In clinical settings, E-coli testing often includes evaluating antibiotic resistance patterns.
Moreover, this information is critical for selecting effective antibiotics and managing antibiotic-resistant strains of E-coli. E-coli testing is used in surveillance programs to track the incidence and patterns of infections. This data helps public health authorities monitor trends and respond to outbreaks effectively.
The UAE government has heavily invested in expanding healthcare infrastructure, including the construction of new hospitals and clinics. This expansion increases the demand for advanced diagnostic testing, including E-coli testing, to ensure the safety and health of patients. According to the International Trade Administration (ITA), in the UAE's 2022 federal budget, a total of USD 15.8 billion (AED 58.931 billion) was approved for public spending, of which 8.4% is dedicated to healthcare.
Based on Test, the market is segmented into Environmental Test, and Clinical Test. Based on End User, the market is segmented into Diagnostic Laboratories, Hospitals, and Physicians Offices. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
List of Key Companies Profiled
- BIOMÉRIEUX
- Bio-Rad Laboratories, Inc.
- Pro Lab diagnostics
- NanoLogix, Inc.
- Thermo Fisher Scientific
- CPI International
- Meridian Bioscience, Inc. (SD Biosensor Co., Ltd.)
- Becton, Dickinson and Company
- IDEXX Laboratories, Inc.
Market Report Segmentation
By Test
- Environmental Test
- Clinical Test
By End User
- Diagnostic Laboratories
- Hospitals
- Physicians Offices
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. LAMEA E-coli Testing Market by Test
Chapter 5. LAMEA E-coli Testing Market by End User
Chapter 6. LAMEA E-coli Testing Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- BIOMÉRIEUX
- Bio-Rad Laboratories, Inc.
- Pro Lab diagnostics
- NanoLogix, Inc.
- Thermo Fisher Scientific
- CPI International
- Meridian Bioscience, Inc. (SD Biosensor Co., Ltd.)
- Becton, Dickinson and Company
- IDEXX Laboratories, Inc.
Methodology
LOADING...
